Article,

Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?

, , , , , , , , , , , , , , , , , , , , , , , , , , , and .
Journal for ImmunoTherapy of Cancer, 10 (5): e003487 (May 2022)
DOI: 10.1136/jitc-2021-003487

Meta data

Tags

Users

  • @scadsfct

Comments and Reviews